Novocure Ltd
- NVCR
- NASDAQ
- Medical devices
- Tumor Treating Fields (TTFields)
$14.07
Today −2.36%Quote Oct 16, 2026, 08:00 PM UTC
−15.85%over the last month
Max drawdown −17.2%From 1-month high −15.8%3 months −11.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.64B
Quote Oct 16
Next earnings
Oct 29
Expected, not confirmed
Analyst target
$26.00
+84.8% from here
Floor
$13.68
2.7% below price
Where the price sits
15 analysts
Analyst range, low to high
$20.00$32.00
- Price $14.07
- Resistance $14.76
- Consensus $26.00
Analysts' average target sits about 85% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NVCRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical devices
Employees
1,605
Founded
2000